InvestorsHub Logo
Followers 87
Posts 6692
Boards Moderated 1
Alias Born 09/18/2009

Re: eb0783 post# 40585

Thursday, 09/21/2023 6:42:31 AM

Thursday, September 21, 2023 6:42:31 AM

Post# of 42925
Yes, that amazing improvement was discovered as a result of an Investigator Initiated IND clinical "FasT CAR" trial in the US. I'm hopeful that lenz was the Investigational New Drug that was used.

https://www.gracellbio.com/pipeline/

I don't know how Gracell's presentation to the Stifel 2023 Immunology and Inflammation Virtual Summit was received yesterday. The webcast wasn't archived. But the Jefferies and Cantor presentations scheduled for Tuesday and Wednesday will be available to review.

https://ir.gracellbio.com/news-events/events-and-presentations

I am hopeful that we will see our second quarter 10-Q by the 25th, before next week's presentations. If we can soon see news regarding the approval of lenz for CMML in Australia, followed-up with this news of our CAR-T enhancement, and possibly including TReg news from TeraImmune, that would be amazing!